Skip to main content
. 2023 Mar 13;55(4):179–193. doi: 10.1152/physiolgenomics.00126.2022

Figure 3.

Figure 3.

Representative images of the positive (CD44; A) and negative (CD34; B) mesenchymal stem cell markers in mesenteric artery cross sections. Sm22 (red) was used as a vascular smooth muscle cell (VSMC) marker, DAPI for nuclei (blue), CD44 and CD34 (green). C: seconday antibody only negative controls. Scale bar = 20 µm.